entertainment -WSS

entertainment

author：comprehensive 2025-09-30 16:28:44 - browse：4374

Adam's take main illustration — Molly Ferguson/STAT

The Food and Drug Administration should halt Cassava Sciences’ ongoing clinical trials in Alzheimer’s disease. That, and other thoughts on the fallout from the City University of New York investigation that raised serious doubts about the science underpinning the company’s experimental drug simufilam.

Patient safety is paramount to the FDA, so stopping Cassava’s two Phase 3 studies is the ethically correct thing to do.The FDA has the power to place clinical holds on experimental drugs when there’s evidence of an unacceptable safety risk to study participants. Simufilam doesn’t appear to be toxic. It’s not causing dangerous side effects. But study participants can also be harmed when they volunteer for a clinical trial based on false or misleading information about a drug’s potential efficacy.

The CUNY committee charged with investigating Cassava’s principal scientific collaborator, the neuroscientist Hoau-Yan Wang, could not definitively prove that Wang faked simufilam data, but that’s only because he refused to turn over original data and primary research records that the committee had requested to examine. Wang also claimed that boxes of research records relevant to the investigation were thrown away. The investigative report was first made public last week in the journal Science.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： Faced with fears of OxyContin misuse, sales reps touted its safety

WSS

Why Charlie Gard's case is so disturbing to Americans

Who are the detained American citizens released from prison in Iran?

Sana to lay off nearly a third of staff, de

House GOP releases memo on Hunter Biden foreign business dealings, reviving old claims

Chemotherapy drug shortage eases slightly but still widespread

Stroke deaths set to near 10 million globally by 2050

hotspot

entertainment

leisure time

Sports medicine is finally prioritizing gender equality

Covid's long

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Colorectal cancer study finds potential in overlooked immune cell

The high cost of giving birth even with insurance

CDC overhauls leadership of center that led response to Covid

At least 13 dead in Texas as scorching temps continue

Colorectal cancer study finds potential in overlooked immune cell

Trump demands the U.S. pay no more for drugs than other countries … again

Faced with fears of OxyContin misuse, sales reps touted its safety

hotspot

A Q&A with the global head of Boehringer Ingelheim's innovation unit

Readout Newsletter: Biotech news, including Moderna's Covid vaccine

The perfect storm of weather conditions that led to the devastating wildfires in Maui

Phenylephrine and the overlooked value of the placebo effect

Analysis of telehealth claims data suggest service duplication

Stroke deaths set to near 10 million globally by 2050

hotspot

knowledge

explore

focus